US Patent Issued to Beam Therapeutics on March 17 for "Fratricide resistant modified immune cells and methods of using the same" (Massachusetts Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,151, issued on March 17, was assigned to Beam Therapeutics Inc. (Cambridge, Mass.).

"Fratricide resistant modified immune cells and methods of using the same" was invented by Jason Gehrke (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention features fratricide resistant modified immune cells (e.g., T- or NK-cells) having enhanced anti-neoplasia activity and methods for producing and using the same. Methods of treating neoplasia (e.g., T- or NK-cell malignancies) using fratricide resistant modified immune cells are also provided."

The patent was filed on Sept. 24, 2021, under Application No. 18/246,656.

*For furth...